University Of Maryland St. Joseph Medical Center
Clinical trials sponsored by University Of Maryland St. Joseph Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a common anti-inflammatory cut opioid use after spinal fusion? Results expected Jun 2027 (estimated)
-
Could a common hormone beat dangerous Post-Surgery low blood pressure?
Disease control Recruiting nowThis study tests whether angiotensin II, a drug that narrows blood vessels, can safely and effectively treat dangerously low blood pressure after heart surgery. About 100 adults undergoing heart surgery with a heart-lung machine will receive the drug as a first-line treatment. Re…
Phase 4 • Sponsor: University of Maryland St. Joseph Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a common anti-inflammatory cut opioid use after spinal fusion?
Symptom relief Recruiting nowThis study tests whether the anti-inflammatory drug ketorolac can lower the amount of strong painkillers (opioids) needed after lumbar spinal fusion surgery. About 140 adults having one- or two-level fusion will receive either ketorolac or a placebo for the first 48 hours after s…
Phase 4 • Sponsor: University of Maryland St. Joseph Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC